JP6386448B2 - ブタインターフェロンアルファ及びブタインターフェロンガンマを同時に発現する組換えアデノウィルス - Google Patents

ブタインターフェロンアルファ及びブタインターフェロンガンマを同時に発現する組換えアデノウィルス Download PDF

Info

Publication number
JP6386448B2
JP6386448B2 JP2015514906A JP2015514906A JP6386448B2 JP 6386448 B2 JP6386448 B2 JP 6386448B2 JP 2015514906 A JP2015514906 A JP 2015514906A JP 2015514906 A JP2015514906 A JP 2015514906A JP 6386448 B2 JP6386448 B2 JP 6386448B2
Authority
JP
Japan
Prior art keywords
porcine
foot
porcine interferon
recombinant adenovirus
mouth disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015514906A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015523858A (ja
JP2015523858A5 (enExample
Inventor
ス ミ キム
ス ミ キム
ジョン ヒョン パク
ジョン ヒョン パク
クァン ニョン リー
クァン ニョン リー
ヨウン ジョン コー
ヨウン ジョン コー
ヒャン シム リー
ヒャン シム リー
ユン キュン シン
ユン キュン シン
ビョウン ハン キム
ビョウン ハン キム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Republic Of Korea Management Ministry Of Agriculture Food And Rural Affairs Animal And Plant Quarantine Agency
Original Assignee
Republic Of Korea Management Ministry Of Agriculture Food And Rural Affairs Animal And Plant Quarantine Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Republic Of Korea Management Ministry Of Agriculture Food And Rural Affairs Animal And Plant Quarantine Agency filed Critical Republic Of Korea Management Ministry Of Agriculture Food And Rural Affairs Animal And Plant Quarantine Agency
Publication of JP2015523858A publication Critical patent/JP2015523858A/ja
Publication of JP2015523858A5 publication Critical patent/JP2015523858A5/ja
Application granted granted Critical
Publication of JP6386448B2 publication Critical patent/JP6386448B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP2015514906A 2012-05-31 2013-05-31 ブタインターフェロンアルファ及びブタインターフェロンガンマを同時に発現する組換えアデノウィルス Active JP6386448B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20120058410A KR101329348B1 (ko) 2012-05-31 2012-05-31 돼지 인터페론 알파-돼지 인터페론 감마를 동시 발현하는 재조합 아데노바이러스
KR10-2012-0058410 2012-05-31
PCT/KR2013/004784 WO2013180501A1 (ko) 2012-05-31 2013-05-31 돼지 인터페론 알파-돼지 인터페론 감마를 동시 발현하는 재조합 아데노바이러스

Publications (3)

Publication Number Publication Date
JP2015523858A JP2015523858A (ja) 2015-08-20
JP2015523858A5 JP2015523858A5 (enExample) 2016-07-21
JP6386448B2 true JP6386448B2 (ja) 2018-09-05

Family

ID=49673627

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015514906A Active JP6386448B2 (ja) 2012-05-31 2013-05-31 ブタインターフェロンアルファ及びブタインターフェロンガンマを同時に発現する組換えアデノウィルス

Country Status (6)

Country Link
EP (1) EP2871240B1 (enExample)
JP (1) JP6386448B2 (enExample)
KR (1) KR101329348B1 (enExample)
CN (1) CN104583410B (enExample)
ES (1) ES2662948T3 (enExample)
WO (1) WO2013180501A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107286257A (zh) * 2017-08-09 2017-10-24 芜湖英特菲尔生物制品产业研究院有限公司 一种重组猪长效干扰素α及制备此长效干扰素的融合蛋白及其制备方法
KR102384683B1 (ko) * 2020-05-07 2022-04-11 대한민국 구제역 바이러스 억제 활성을 갖는 신규한 돼지 인터페론-알파 융합 단백질 및 이의 용도
CN115595312A (zh) * 2021-06-28 2023-01-13 中国农业大学（Cn） 一种重组腺病毒及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8058248B2 (en) * 2001-04-26 2011-11-15 The United States Of America As Represented By The Secretary Of Agriculture Foot and mouth disease virus vaccine comprising interferons
US7485291B2 (en) 2003-06-03 2009-02-03 Cell Genesys, Inc. Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
US7632509B2 (en) 2005-07-19 2009-12-15 Biosante Pharmaceuticals, Inc. Methods to express recombinant proteins from lentiviral vectors
WO2007059461A2 (en) * 2005-11-10 2007-05-24 Genvec, Inc. Adenoviral vector-based foot-and-mouth disease vaccine
US7833533B2 (en) * 2008-04-24 2010-11-16 The United States Of America As Represented By The Secretary Of Agriculture Enhanced antiviral activity against foot and mouth disease

Also Published As

Publication number Publication date
JP2015523858A (ja) 2015-08-20
WO2013180501A1 (ko) 2013-12-05
EP2871240A4 (en) 2016-01-27
EP2871240A1 (en) 2015-05-13
EP2871240B1 (en) 2017-12-20
CN104583410A (zh) 2015-04-29
ES2662948T3 (es) 2018-04-10
KR101329348B1 (ko) 2013-11-15
CN104583410B (zh) 2017-09-22

Similar Documents

Publication Publication Date Title
Chen et al. Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo
RU2711371C2 (ru) Аденовирус, содержащий альбумин-связывающий участок
JP2018520997A5 (enExample)
Wu et al. Adenovirus-mediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus
JP2015057052A5 (enExample)
JP2019506175A5 (enExample)
Kim et al. A recombinant adenovirus bicistronically expressing porcine interferon-α and interferon-γ enhances antiviral effects against foot-and-mouth disease virus
WO2011072247A8 (en) Pathogen restriction factors
EA027784B1 (ru) Комбинированная вакцина против кори и вируса папилломы человека
JP2022180463A (ja) 新規免疫化剤および使用方法
Yan et al. Production of transgenic pigs over-expressing the antiviral gene Mx1
Steffensen et al. Pre-existing vector immunity does not prevent replication deficient adenovirus from inducing efficient CD8 T-cell memory and recall responses
Ahanger et al. Protection of shrimp Penaeus monodon from WSSV infection using antisense constructs
JP2015523858A (ja) ブタインターフェロンアルファ及びブタインターフェロンガンマを同時に発現する組換えアデノウィルス
Ho et al. Double-stranded RNA confers both preventive and therapeutic effects against Penaeus stylirostris densovirus (PstDNV) in Litopenaeus vannamei
RU2013102413A (ru) Парапоксвирусные векторы
ES2439954T3 (es) Vectores víricos recombinantes para la prevención y la protección contra la infección por alfavirus
ES2375061T3 (es) Virus de replicación competente capaces de silenciar la expresión de un factor de inhibición de virus.
Fei et al. A fish-specific antimicrobial peptide Ms Piscidin2 inactivates MSRV and confers protection in largemouth bass
Zenke et al. Development of siRNA expression vector utilizing rock bream β-actin promoter: a potential therapeutic tool against viral infection in fish
Lee et al. Superior protective efficacy of genotype IVa-based single-cycle viral hemorrhagic septicemia virus (VHSV) vaccine compared to formalin-killed VHSV vaccine against VHSV genotype Ia in rainbow trout (Oncorhynchus mykiss)
Khimmakthong et al. Stimulating the immune response of Litopenaeus vannamei using the phagocytosis activating protein (PAP) gene
Kim et al. Generation of recombinant viral hemorrhagic septicemia viruses (VHSVs) harboring G gene of hirame rhabdovirus (HIRRV) and their ability to induce serum neutralization activity in olive flounder (Paralichthys olivaceus)
Kim et al. Over-passage of epithelioma papulosum cyprini (EPC) cells increased viral hemorrhagic septicemia virus (VHSV) replication
JP2008503569A5 (enExample)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160524

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160530

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170418

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170718

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170919

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180123

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180326

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180717

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180809

R150 Certificate of patent or registration of utility model

Ref document number: 6386448

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250